Correlation Between EirGenix and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EirGenix and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EirGenix and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EirGenix and Medigen Vaccine Biologics, you can compare the effects of market volatilities on EirGenix and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EirGenix with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of EirGenix and Medigen Vaccine.

Diversification Opportunities for EirGenix and Medigen Vaccine

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between EirGenix and Medigen is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding EirGenix and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and EirGenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EirGenix are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of EirGenix i.e., EirGenix and Medigen Vaccine go up and down completely randomly.

Pair Corralation between EirGenix and Medigen Vaccine

Assuming the 90 days trading horizon EirGenix is expected to generate 3.2 times less return on investment than Medigen Vaccine. But when comparing it to its historical volatility, EirGenix is 1.97 times less risky than Medigen Vaccine. It trades about 0.31 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about 0.5 of returns per unit of risk over similar time horizon. If you would invest  3,525  in Medigen Vaccine Biologics on November 3, 2024 and sell it today you would earn a total of  1,380  from holding Medigen Vaccine Biologics or generate 39.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

EirGenix  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
EirGenix 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EirGenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

EirGenix and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EirGenix and Medigen Vaccine

The main advantage of trading using opposite EirGenix and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EirGenix position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind EirGenix and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume